Medical Treatment of Cushing's Disease

S. Hopkins, Maria Fleseriu

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Surgery remains the principal treatment modality in Cushing's disease, but up to half of the patients might need additional treatment because of persistent or recurrent disease during their lifetime. Medical therapy plays an important role in control of hypercortisolemia in patients who are not surgical candidates, who fail remission or develop a recurrence after surgery, or who are critically ill awaiting surgery. Medical therapies for Cushing's disease can be classified into three major categories: pituitary-directed neuromodulators of adrenocorticotropic hormone, adrenal steroidogenesis inhibitors, and glucocorticoid receptor blockers. This chapter reviews the mechanism of action, efficacy, adverse reactions, and role of currently available medications for the treatment of Cushing's disease. Additionally, medications under investigation, use of combination therapies, and treatment of Cushing's disease in special populations, including treatment in pregnancy and acutely ill states of hypercortisolemia, are discussed.

Original languageEnglish (US)
Title of host publicationCushing's Disease
Subtitle of host publicationAn Often Misdiagnosed and Not So Rare Disorder
PublisherElsevier Inc.
Pages103-123
Number of pages21
ISBN (Electronic)9780128043905
ISBN (Print)9780128043400
DOIs
StatePublished - Nov 14 2016

Fingerprint

Pituitary ACTH Hypersecretion
Therapeutics
Play Therapy
Glucocorticoid Receptors
Critical Illness
Adrenocorticotropic Hormone
Neurotransmitter Agents
Recurrence
Pregnancy
Population

Keywords

  • Cabergoline
  • Cushing's disease
  • Ketoconazole
  • Levoketoconazole
  • Medical therapy
  • Metyrapone
  • Mifepristone
  • Osilodrostat
  • Pasireotide

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hopkins, S., & Fleseriu, M. (2016). Medical Treatment of Cushing's Disease. In Cushing's Disease: An Often Misdiagnosed and Not So Rare Disorder (pp. 103-123). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-804340-0.00007-3

Medical Treatment of Cushing's Disease. / Hopkins, S.; Fleseriu, Maria.

Cushing's Disease: An Often Misdiagnosed and Not So Rare Disorder. Elsevier Inc., 2016. p. 103-123.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hopkins, S & Fleseriu, M 2016, Medical Treatment of Cushing's Disease. in Cushing's Disease: An Often Misdiagnosed and Not So Rare Disorder. Elsevier Inc., pp. 103-123. https://doi.org/10.1016/B978-0-12-804340-0.00007-3
Hopkins S, Fleseriu M. Medical Treatment of Cushing's Disease. In Cushing's Disease: An Often Misdiagnosed and Not So Rare Disorder. Elsevier Inc. 2016. p. 103-123 https://doi.org/10.1016/B978-0-12-804340-0.00007-3
Hopkins, S. ; Fleseriu, Maria. / Medical Treatment of Cushing's Disease. Cushing's Disease: An Often Misdiagnosed and Not So Rare Disorder. Elsevier Inc., 2016. pp. 103-123
@inbook{44e8546a784140df9fd3c3781ed6496b,
title = "Medical Treatment of Cushing's Disease",
abstract = "Surgery remains the principal treatment modality in Cushing's disease, but up to half of the patients might need additional treatment because of persistent or recurrent disease during their lifetime. Medical therapy plays an important role in control of hypercortisolemia in patients who are not surgical candidates, who fail remission or develop a recurrence after surgery, or who are critically ill awaiting surgery. Medical therapies for Cushing's disease can be classified into three major categories: pituitary-directed neuromodulators of adrenocorticotropic hormone, adrenal steroidogenesis inhibitors, and glucocorticoid receptor blockers. This chapter reviews the mechanism of action, efficacy, adverse reactions, and role of currently available medications for the treatment of Cushing's disease. Additionally, medications under investigation, use of combination therapies, and treatment of Cushing's disease in special populations, including treatment in pregnancy and acutely ill states of hypercortisolemia, are discussed.",
keywords = "Cabergoline, Cushing's disease, Ketoconazole, Levoketoconazole, Medical therapy, Metyrapone, Mifepristone, Osilodrostat, Pasireotide",
author = "S. Hopkins and Maria Fleseriu",
year = "2016",
month = "11",
day = "14",
doi = "10.1016/B978-0-12-804340-0.00007-3",
language = "English (US)",
isbn = "9780128043400",
pages = "103--123",
booktitle = "Cushing's Disease",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Medical Treatment of Cushing's Disease

AU - Hopkins, S.

AU - Fleseriu, Maria

PY - 2016/11/14

Y1 - 2016/11/14

N2 - Surgery remains the principal treatment modality in Cushing's disease, but up to half of the patients might need additional treatment because of persistent or recurrent disease during their lifetime. Medical therapy plays an important role in control of hypercortisolemia in patients who are not surgical candidates, who fail remission or develop a recurrence after surgery, or who are critically ill awaiting surgery. Medical therapies for Cushing's disease can be classified into three major categories: pituitary-directed neuromodulators of adrenocorticotropic hormone, adrenal steroidogenesis inhibitors, and glucocorticoid receptor blockers. This chapter reviews the mechanism of action, efficacy, adverse reactions, and role of currently available medications for the treatment of Cushing's disease. Additionally, medications under investigation, use of combination therapies, and treatment of Cushing's disease in special populations, including treatment in pregnancy and acutely ill states of hypercortisolemia, are discussed.

AB - Surgery remains the principal treatment modality in Cushing's disease, but up to half of the patients might need additional treatment because of persistent or recurrent disease during their lifetime. Medical therapy plays an important role in control of hypercortisolemia in patients who are not surgical candidates, who fail remission or develop a recurrence after surgery, or who are critically ill awaiting surgery. Medical therapies for Cushing's disease can be classified into three major categories: pituitary-directed neuromodulators of adrenocorticotropic hormone, adrenal steroidogenesis inhibitors, and glucocorticoid receptor blockers. This chapter reviews the mechanism of action, efficacy, adverse reactions, and role of currently available medications for the treatment of Cushing's disease. Additionally, medications under investigation, use of combination therapies, and treatment of Cushing's disease in special populations, including treatment in pregnancy and acutely ill states of hypercortisolemia, are discussed.

KW - Cabergoline

KW - Cushing's disease

KW - Ketoconazole

KW - Levoketoconazole

KW - Medical therapy

KW - Metyrapone

KW - Mifepristone

KW - Osilodrostat

KW - Pasireotide

UR - http://www.scopus.com/inward/record.url?scp=85027164294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027164294&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-804340-0.00007-3

DO - 10.1016/B978-0-12-804340-0.00007-3

M3 - Chapter

AN - SCOPUS:85027164294

SN - 9780128043400

SP - 103

EP - 123

BT - Cushing's Disease

PB - Elsevier Inc.

ER -